Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00039
http://purl.obolibrary.org/obo/dinto_DB00039
|
|---|---|
| Preferred Name | palifermin |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | palifermin
|
|---|---|
| label | palifermin
|
| DBSynonym |
fgf-7
keratinocyte growth factor precursor
kgf
fibroblast growth factor- 7
hbgf-7
|
| ATCCode | V03AF08
|
| Definition | Palifermin is a recombinant human keratinocyte growth factor (KGF). It is 140 residues long, and is produced using E. coli.
|
| has pharmacological target | |
| type | |
| binds | |
| AHFScode | 84:16.00
|
| xref |
Drugs.com:http://www.drugs.com/cdi/palifermin.html
GenBank:M60828
PharmGKB:PA164744014
Drugs Product Database (DPD):2274221
RxList:http://www.rxlist.com/cgi/generic/kepivance.htm
National Drug Code Directory:55513-520-06
UniProtKB:P21781
Wikipedia:http://en.wikipedia.org/wiki/Palifermin
See more
See less
|
| CASRN | 162394-19-6
|
| prefixIRI | obo2:dinto_DB00039
|
| related with | |
| may interact with | |
| DBBrand | kepivance (amgen inc)
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |